These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 25060070)

  • 21. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
    Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD
    Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Sushi repeat-containing protein X-linked 2 is associated with progression of colorectal cancer.
    Liu KL; Wu J; Zhou Y; Fan JH
    Med Oncol; 2015 Apr; 32(4):99. PubMed ID: 25737434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells.
    Chen J; Zhao J; Ding J; Wang Z; Du J; Wu C
    Braz J Med Biol Res; 2020; 53(7):e9230. PubMed ID: 32520208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
    Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
    Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
    Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
    J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions.
    Broussard EK; Kim R; Wiley JC; Marquez JP; Annis JE; Pritchard D; Disis ML
    Cancer Prev Res (Phila); 2013 Jul; 6(7):666-74. PubMed ID: 23682078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
    Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
    BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines.
    Walker F; Zhang HH; Odorizzi A; Burgess AW
    PLoS One; 2011; 6(7):e22733. PubMed ID: 21829496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
    Song Y; Xu Y; Wang Z; Chen Y; Yue Z; Gao P; Xing C; Xu H
    Int J Cancer; 2012 Sep; 131(5):1042-51. PubMed ID: 22020560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway.
    Yan G; Li S; Yue M; Li C; Kang Z
    Life Sci; 2021 Jan; 264():118726. PubMed ID: 33160990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
    Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-4 functions as a tumor suppressor of human colorectal cancer.
    Satelli A; Rao PS; Thirumala S; Rao US
    Int J Cancer; 2011 Aug; 129(4):799-809. PubMed ID: 21064109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.
    Qu L; Liang L; Su J; Yang Z
    Eur J Cancer Prev; 2013 Nov; 22(6):512-22. PubMed ID: 23765094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and clinical significance of hedgehog signaling pathway related components in colorectal cancer.
    Wang H; Li YY; Wu YY; Nie YQ
    Asian Pac J Cancer Prev; 2012; 13(5):2319-24. PubMed ID: 22901214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.